Publications by authors named "C Veyret"
Article Synopsis
- The study compared two types of catheters (PICCs and PORTs) used for chemotherapy in breast cancer patients to see which is safer.
- It found that while both types had some problems, PICCs caused more issues and discomfort than PORTs.
- The research suggests that for treating breast cancer, PORTs are the better choice because they have fewer complications.
Article Synopsis
- - The study investigated immediate hypersensitivity reactions (IH) to iodinated and gadolinium-based contrast media (ICM; GBCM), focusing on differentiating between allergic and non-allergic responses, which is crucial for future medical treatment decisions.
- - Over 245 patients were analyzed through skin tests and other clinical evaluations, revealing an allergic reaction rate of 19.6% for ICM and 27.8% for GBCM, with notable cross-reactivity among patients.
- - The findings indicated that allergic IH was linked to more severe reactions and quicker onset than non-allergic IH, highlighting the need for more sensitive skin testing methods to better identify allergic responses to contrast agents.
Purpose: Luminal breast cancer has a long natural history, with recurrences continuing beyond 10 years after diagnosis. We analyzed long-term follow-up (LTFU) of efficacy outcomes and adverse events in the Breast International Group (BIG) 1-98 study reported after a median follow-up of 12.6 years.
View Article and Find Full Text PDFBackground: The likelihood of menses recovery varies greatly in premenopausal patients receiving adjuvant chemotherapy for breast cancer. Quantifying this probability for each patient could better inform the chemotherapy discussion and individualize fertility counseling. We performed a pooled analysis of the PACS04 and PACS05 adjuvant randomized trials to develop a nomogram to estimate the probability of menses recovery at 3, 6, and 18 months after the end of adjuvant chemotherapy.
View Article and Find Full Text PDFBackground: Group-based trajectory modeling is particularly important to identify subgroups of patients with pathological cognitive changes after cancer treatment. To date, only one study has explored cognitive trajectories in older patients with cancer. The present article describes objective cognitive changes before to after adjuvant treatment in older adults with early-stage breast cancer (EBC) after adjuvant treatment compared with healthy controls.
View Article and Find Full Text PDF